Breaking the Efflux Barrier: P-Glycoprotein and Emerging Strategies to Overcome Multidrug Resistance in Cancer
Cancers · 24.06.2026 · 18 (13) · 2047
DOI: 10.3390/cancers18132047 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 24.06.2026. Verfasst von Alina Crenguța Nicolae und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 020956 Bucharest, Romania. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 202 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Multidrug resistance (MDR) remains a major obstacle in cancer therapy, driving treatment failure and disease progression across diverse malignancies. A key determinant of MDR is the overexpression of ATP-binding cassette (ABC) transporters, particularly P-glycoprotein (P-gp/ABCB1), which actively effluxes structurally diverse chemotherapeutic agents and reduces their intracellular accumulation. Despite extensive investigation, clinically effective strategies to overcome P-gp-mediated resistance remain limited. This review provides a comprehensive analysis of the molecular mechanisms underlying P-gp function, including its structural organization, regulation of expression, and role in cellular drug disposition. We highlight the interplay between P-gp activity, oxidative stress, metabolic reprogramming and the tumor microenvironment, emphasizing the complexity of MDR as a dynamic and adaptive process. Emerging therapeutic approaches targeting P-gp-mediated resistance are also discussed, including natural bioactive compounds, nanotechnology-based drug delivery systems, polymeric carriers and novel anticancer agents designed to evade efflux mechanisms. Integrating mechanistic insights with advanced pharmacological strategies may improve intracellular drug retention and therapeutic efficacy. A deeper understanding of P-gp-driven MDR is essential for the development of effective interventions aimed at overcoming drug resistance and improving clinical outcomes in cancer patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 020956 Bucharest, Romania.
- Clinical Neuroscience Department, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
- Academy of Romanian Scientists, 050045 Bucharest, Romania.
- Department of Physics and Informatics, Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 020956 Bucharest, Romania.
- Department of Clinical Laboratory and Food Safety, Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 020956 Bucharest, Romania.
ORCID-Profile: Alina Crenguța Nicolae, Carmen Adella Sîrbu, Ion-Bogdan Dumitrescu, Cristina Manuela Drăgoi
Zitieren
APA
Nicolae, A. C., Sîrbu, C. A., Dumitrescu, I. B., Moroşan, E., & Drăgoi, C. M. (2026). Breaking the Efflux Barrier: P-Glycoprotein and Emerging Strategies to Overcome Multidrug Resistance in Cancer. Cancers, 18(13), 2047. https://doi.org/10.3390/cancers18132047
Vancouver
Nicolae AC, Sîrbu CA, Dumitrescu IB, Moroşan E, Drăgoi CM. Breaking the Efflux Barrier: P-Glycoprotein and Emerging Strategies to Overcome Multidrug Resistance in Cancer. Cancers. 2026;18(13):2047. doi:10.3390/cancers18132047
BibTeX
@article{Nicolae2026,
author = {Nicolae, Alina Crenguța and Sîrbu, Carmen Adella and Dumitrescu, Ion-Bogdan and Moroşan, Elena and Drăgoi, Cristina Manuela},
title = {Breaking the Efflux Barrier: P-Glycoprotein and Emerging Strategies to Overcome Multidrug Resistance in Cancer},
journal = {Cancers},
year = {2026},
volume = {18},
number = {13},
pages = {2047},
doi = {10.3390/cancers18132047}
}
EUVIMED